Cambridge Investment Research Advisors, Inc. Lantheus Holdings, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $36.4 Billion
- Q3 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 64,341 shares of LNTH stock, worth $3.41 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
64,341
Previous 36,271
77.39%
Holding current value
$3.41 Million
Previous $2.97 Million
11.15%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding LNTH
# of Institutions
478Shares Held
68.9MCall Options Held
522KPut Options Held
312K-
Black Rock Inc. New York, NY8.6MShares$456 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.95MShares$369 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X06.68MShares$354 Million0.17% of portfolio
-
Morgan Stanley New York, NY3.88MShares$206 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.48MShares$184 Million0.77% of portfolio
About Lantheus Holdings, Inc.
- Ticker LNTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 68,741,904
- Market Cap $3.64B
- Description
- Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...